Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia

NCT00237809 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT00237809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00237809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
Lead sponsor
Yale University
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2002
Completion date
September 30, 2012
Enrollment
104 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia